Assignee
BLUEFIN BIOMEDICINE INC
US·17 granted patents·6 pending applications·20 citations·filing 2014–2025
Top patents by PatentIndex Score
23 records- 0193US12138314B2Anti-CUB domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereofBLUEFIN BIOMEDICINE INC·Filed 2024·Granted Nov 12, 2024·1 cites·8 claims
- 0293US12138313B2Anti-cub domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereofBLUEFIN BIOMEDICINE INC·Filed 2024·Granted Nov 12, 2024·1 cites·8 claims
- 0389US11702481B2Anti-cub domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereofBLUEFIN BIOMEDICINE INC·Filed 2017·Granted Jul 18, 2023·3 cites·19 claims
- 0489US11312769B2Anti-TMEFF1 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2018·Granted Apr 26, 2022·4 cites·14 claims
- 0588US11981732B2Anti-TMEFF1 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2022·Granted May 14, 2024·1 cites·19 claims
- 0688US11634486B2Anti-SEZ6L2 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2017·Granted Apr 25, 2023·3 cites·4 claims
- 0783US12491256B2Anti-cub domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereofBLUEFIN BIOMEDICINE INC·Filed 2023·Granted Dec 9, 2025·0 cites·18 claims
- 0882US12473358B2Anti-TMEFF1 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2024·Granted Nov 18, 2025·0 cites·19 claims
- 0982US11434303B2Anti-LY6H antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2018·Granted Sep 6, 2022·1 cites·12 claims
- 1079US2025092132A1Anti-ilt3 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2024·Application pending·0 cites
- 1178US11932694B2Anti-VTCN1 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2018·Granted Mar 19, 2024·1 cites·14 claims
- 1278US10208125B2Anti-mucin 1 binding agents and uses thereofBLUEFIN BIOMEDICINE INC·Filed 2014·Granted Feb 19, 2019·4 cites·44 claims
- 1377US2026060995A1Anti-vtcn1 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2025·Application pending·0 cites
- 1477US2025368747A1Anti-il1rap antibodies and compositionsBLUEFIN BIOMEDICINE INC·Filed 2025·Application pending·0 cites
- 1576US12427163B2Anti-VTCN1 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2024·Granted Sep 30, 2025·0 cites·14 claims
- 1676US12296006B2Anti-LY6H antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2022·Granted May 13, 2025·0 cites·14 claims
- 1776US11267886B2Anti-ILT3 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2018·Granted Mar 8, 2022·1 cites·13 claims
- 1875US2023331839A1Anti-sez6l2 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2023·Application pending·0 cites
- 1973US12110326B2Anti-ILT3 antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2022·Granted Oct 8, 2024·0 cites·22 claims
- 2073US2025319180A1Anti-ly6h antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2025·Application pending·0 cites
- 2169US12350347B2Nucleic acids encoding anti-IL1RAP antibodies and their usesBLUEFIN BIOMEDICINE INC·Filed 2021·Granted Jul 8, 2025·0 cites·13 claims
- 2266US2026008856A1Methods of treating disease using anti-il1rap antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2023·Application pending·0 cites
- 2359US11248054B2Anti-IL1RAP antibodies and antibody drug conjugatesBLUEFIN BIOMEDICINE INC·Filed 2018·Granted Feb 15, 2022·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when BLUEFIN BIOMEDICINE INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →